Glenfield hospital
Leicester LE3 9QP
5 studies enrolling now · 28 studies all time
What they study most
Acute Myocardial Infarction (AMI), Asthma, Atherosclerosis of Extremities, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Atrial Flutter, Bleeding, COVID-19, CRC With Atopic Asthma, CRC With Chronic Obstructive Pulmonary Disease, CRC With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis, Cardiovascular Risk
Studies at this site
- A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — Recruiting now
- A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy — Recruiting now
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity — Recruiting now
- ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
- Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk — Recruiting now
- CHAMPION-AF Clinical Trial — Running, not enrolling
- A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease — Completed
- A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough — Completed
- Enlighten Study: The EV-ICD Post Approval Registry — Running, not enrolling
- Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction — Completed
- Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease) — Completed
- Study Evaluating Betrixaban in Pediatric Participants — Stopped early
- Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study — Completed
- Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 — Completed
- Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy — Running, not enrolling
- EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
- EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
- Personalized CRT - MPP Post Approval Study — Completed
- Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma — Completed
- Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) — Completed
- Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT) — Stopped early
- A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Participants With Uncontrolled Asthma — Completed
- INcrease Of VAgal TonE in CHF — Stopped early
- Clinical Study to Evaluate the Catheter Robotics Amigo for Performing Right-Sided Electrophysiology Mapping Studies — Completed
- A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL — Completed
- SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries — Status unconfirmed
- Efficacy and Safety/Tolerability of Grass MATA MPL — Completed